Corina Thomet
Research Subjects
Corina Thomet has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Philip Moons
KU Leuven Department of Public Health and Primary Care, KU Leuven , Kapucijnenvoer 7 PB7001, 3000 Leuven
5 shared publications Adrienne H. Kovacs
Toronto Congenital Cardiac Center for Adults, Peter Munk Cardiac Center, University Health Network, University of Toronto, Toronto, Canada; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon
4 shared publicationsKoen Luyckx
KU Leuven School Psychology and Development in Context, KU Leuven, Leuven, Belgium; UNIBS, University of the Free State, Bloemfontein, South Africa
4 shared publicationsLuis Alday
Division of Cardiology, Hospital de Niños, Córdoba, Argentina
4 shared publicationsMaayke A. Sluman
Coronel Institute of Occupational Health, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Department of Cardiology, Jeroen Bosch Hospital, 's Hertogenbosch, The Netherlands
4 shared publicationsMikael Dellborg
Centre for Person-Centred Care (GPCC), University of Gothenburg, Gothenburg, Sweden; Adult Congenital Heart Unit, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden; Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, Sweden
4 shared publications
Latest Publications
- Open Access
- 24 April 2024
- Published by Oxford University Press (OUP) in European Journal of Cardiovascular Nursing
- Vol. 23 (7) , e159
How and why ESC guidelines should be implemented to improve health support in different countries
Clinical guidelines integrate the best available evidence for evidence-based practice. However, they are infrequently applied in everyday clinical practice.1,2 Guidelines are not rigid rules or objectives to be blindly followed. Instead, they should complement and support the decision-making process in nursing practice. Guidelines significantly contribute to enhancing the quality of patient care and health systems, promoting uniformity, individualized care, safety, and aid in cost reduction.1 A crucial question persists: are cardiovascular nurses using guidelines to provide the best possible care for all their patients? Previous results have revealed that the main barriers are a lack of knowledge and challenges associated with their implementation.3
- 24 April 2024
- Published by Oxford University Press (OUP) in European Journal of Cardiovascular Nursing
- Vol. 23 (7) , e159
Open AccessHow and why ESC guidelines should be implemented to improve health support in different countries
Clinical guidelines integrate the best available evidence for evidence-based practice. However, they are infrequently applied in everyday clinical practice.1,2 Guidelines are not rigid rules or objectives to be blindly followed. Instead, they should complement and support the decision-making process in nursing practice. Guidelines significantly contribute to enhancing the quality of patient care and health systems, promoting uniformity, individualized care, safety, and aid in cost reduction.1 A crucial question persists: are cardiovascular nurses using guidelines to provide the best possible care for all their patients? Previous results have revealed that the main barriers are a lack of knowledge and challenges associated with their implementation.3
- 1 March 2022
- Published by Wiley in Nursing in Critical Care
- Vol. 27 (2) , 145-147
Emerging adulthood: The ageing problem of congenital heart disease
- 1 March 2022
- Published by Wiley in Nursing in Critical Care
- Vol. 27 (2) , 145-147
Emerging adulthood: The ageing problem of congenital heart disease
- Open Access
- 1 April 2021
- Published by Elsevier in The American Journal of Cardiology
- Vol. 145, 135-142
Patient-Reported Outcomes in Adults With Congenital Heart Disease Following Hospitalization (from APPROACH-IS)
- 1 April 2021
- Published by Elsevier in The American Journal of Cardiology
- Vol. 145, 135-142
Open AccessPatient-Reported Outcomes in Adults With Congenital Heart Disease Following Hospitalization (from APPROACH-IS)
- 29 August 2020
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 41 (43) , 4200-4210
Recommendations for advance care planning in adults with congenital heart disease: a position paper from the ESC Working Group of Adult Congenital Heart Disease, the Association of Cardiovascular Nursing and Allied Professions (ACNAP), the European Association for Palliative Care (EAPC), and the International Society for Adult Congenital Heart Disease (ISACHD)
Survival prospects in adults with congenital heart disease (CHD), although improved in recent decades, still remain below expectations for the general population. Patients and their loved ones benefit from preparation for both unexpected and predictable deaths, sometimes preceded by a prolonged period of declining health. Hence, advance care planning (ACP) is an integral part of comprehensive care for adults with CHD. This position paper summarizes evidence regarding benefits of and patients’ preferences for ACP and provides practical advice regarding the implementation of ACP processes within clinical adult CHD practice. We suggest that ACP be delivered as a structured process across different stages, with content dependent upon the anticipated disease progression. We acknowledge potential barriers to initiate ACP discussions and emphasize the importance of a sensitive and situation-specific communication style. Conclusions presented in this article reflect agreed expert opinions and include both patient and provider perspectives.
- 29 August 2020
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 41 (43) , 4200-4210
Recommendations for advance care planning in adults with congenital heart disease: a position paper from the ESC Working Group of Adult Congenital Heart Disease, the Association of Cardiovascular Nursing and Allied Professions (ACNAP), the European Association for Palliative Care (EAPC), and the International Society for Adult Congenital Heart Disease (ISACHD)
Survival prospects in adults with congenital heart disease (CHD), although improved in recent decades, still remain below expectations for the general population. Patients and their loved ones benefit from preparation for both unexpected and predictable deaths, sometimes preceded by a prolonged period of declining health. Hence, advance care planning (ACP) is an integral part of comprehensive care for adults with CHD. This position paper summarizes evidence regarding benefits of and patients’ preferences for ACP and provides practical advice regarding the implementation of ACP processes within clinical adult CHD practice. We suggest that ACP be delivered as a structured process across different stages, with content dependent upon the anticipated disease progression. We acknowledge potential barriers to initiate ACP discussions and emphasize the importance of a sensitive and situation-specific communication style. Conclusions presented in this article reflect agreed expert opinions and include both patient and provider perspectives.
- 1 December 2019
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 35 (12) , 1842-1850
Prevalence and Effects of Cigarette Smoking, Cannabis Consumption, and Co-use in Adults From 15 Countries With Congenital Heart Disease
- 1 December 2019
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 35 (12) , 1842-1850
Prevalence and Effects of Cigarette Smoking, Cannabis Consumption, and Co-use in Adults From 15 Countries With Congenital Heart Disease
- Open Access
- 1 March 2019
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 22, 20-25
Geographical variation and predictors of physical activity level in adults with congenital heart disease
- 1 March 2019
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 22, 20-25
Open AccessGeographical variation and predictors of physical activity level in adults with congenital heart disease
- 1 October 2017
- Published by Elsevier in International Journal of Cardiology
- Vol. 244, 130-138
Illness perceptions in adult congenital heart disease: A multi-center international study
- 1 October 2017
- Published by Elsevier in International Journal of Cardiology
- Vol. 244, 130-138
Illness perceptions in adult congenital heart disease: A multi-center international study
Cardiopulmonary adaptation to short-term high altitude exposure in adult Fontan patients
Objective High altitude-related hypoxia induces pulmonary vasoconstriction. In Fontan patients without a contractile subpulmonary ventricle, an increase in pulmonary artery pressure is expected to decrease circulatory output and reduce exercise capacity. This study investigates the direct effects of short-term high altitude exposure on pulmonary blood flow (PBF) and exercise capacity in Fontan patients. Methods 16 adult Fontan patients (mean age 28±7 years, 56% female) and 14 matched controls underwent cardiopulmonary exercise testing with measurement of PBF with a gas rebreathing system at 540 m (low altitude) and at 3454 m (high altitude) within 12 weeks. Results PBF at rest and at exercise was higher in controls than in Fontan patients, both at low and high altitude. PBF increased twofold in Fontan patients and 2.8-fold in the control group during submaximal exercise, with no significant difference between low and high altitude (p=0.290). A reduction in peak oxygen uptake at high compared with low altitude was observed in Fontan patients (22.8±5.1 and 20.5±3.8 mL/min/kg, pConclusions Short-term high altitude exposure has no negative impact on PBF and exercise capacity in Fontan patients when compared with controls, and was clinically well tolerated. Trial registration number NCT02237274: Results.
Cardiopulmonary adaptation to short-term high altitude exposure in adult Fontan patients
Objective High altitude-related hypoxia induces pulmonary vasoconstriction. In Fontan patients without a contractile subpulmonary ventricle, an increase in pulmonary artery pressure is expected to decrease circulatory output and reduce exercise capacity. This study investigates the direct effects of short-term high altitude exposure on pulmonary blood flow (PBF) and exercise capacity in Fontan patients. Methods 16 adult Fontan patients (mean age 28±7 years, 56% female) and 14 matched controls underwent cardiopulmonary exercise testing with measurement of PBF with a gas rebreathing system at 540 m (low altitude) and at 3454 m (high altitude) within 12 weeks. Results PBF at rest and at exercise was higher in controls than in Fontan patients, both at low and high altitude. PBF increased twofold in Fontan patients and 2.8-fold in the control group during submaximal exercise, with no significant difference between low and high altitude (p=0.290). A reduction in peak oxygen uptake at high compared with low altitude was observed in Fontan patients (22.8±5.1 and 20.5±3.8 mL/min/kg, pConclusions Short-term high altitude exposure has no negative impact on PBF and exercise capacity in Fontan patients when compared with controls, and was clinically well tolerated. Trial registration number NCT02237274: Results.